VICTORIA, BC, Jan. 3 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation today announced that Richard Glickman will be presenting at the JP Morgan Healthcare Conference in San Francisco.
The 25 minute presentation followed by a 25 minute break out session will take place on Wednesday, January 11th at 8:00 am PST at the Westin St. Francis.
A live audio webcast of Mr. Glickman's presentation will be available to all interested parties through a link posted on Aspreva's website at www.aspreva.com in the Investors section.
About Aspreva Pharmaceuticals
Aspreva is an emerging pharmaceutical company focused on identifying, developing and, upon regulatory approval, commercializing new indications for approved drugs and late stage drug candidates for patients living with less common diseases. Aspreva's "Indication Partnering" strategy allows its partners to maintain core brand focus while extending the benefits of their medicines to a broader patient population. Aspreva is listed on the Nasdaq National Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV".
For further information please contact: Sage Baker Director, Corporate Communications Aspreva Pharmaceuticals 250-744-2488 ext. 270 sbaker@aspreva.com
Aspreva PharmaceuticalsCONTACT: Sage Baker, Director, Corporate Communications, AsprevaPharmaceuticals, (250) 744-2488 ext. 270, sbaker@aspreva.com
